The IMPT serves as the ‘communications and information hub’ for the field of multipurpose prevention technologies (MPTs).
Our resource center features a searchable database, providing you access to global MPT research, technical webinars, trainee and career resources, advocacy tools, and more. Search our resources!
Resource Search
Multipurpose Prevention Technologies: Opportunities and Challenges to Ensure Advancement of the Most Promising MPTs
Annual National Reproductive Health Conference
10-13 August 2021 Annual National Reproductive Health Conference San Francisco, CA, USA
Giving voice to the end-user: input on multipurpose prevention technologies from the perspectives of young women in Kenya and South Africa
Compounds with Potential Activity to Prevent or Treat HIV and Other Sexually Transmitted Infections: A Landscape Review
Compounds with Potential Activity to Prevent or Treat HIV and Other Sexually Transmitted Infections: A Landscape Review July, 2021 click to view Report In this Report: Topic(s): Compounds with Multiple Potential Activities
Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake
MPT Mini Video Series
The IMPT introduces its MPT Mini Video Series, a new audiovisual project aimed to raise awareness about MPTs and bring digestible bits of the MPT story to your fingertips. The series kicks off with an introduction to the first-ever MPT in “King Minos & the First Condom.” In the second video, “If I Could Talk to the Scientists…”, we hear first-hand from health professionals at Wits RHI on the potential of MPTs to improve sexual and reproductive health. Stay tuned for upcoming videos in the series bringing you more voices from women around the world.
Opportunities and Challenges for MPT & HIV Prevention Drug Delivery Approaches
New Frontiers in STI/HIV Prevention & Family Planning: The Promise of Multipurpose Prevention Technologies
Combining Active Pharmaceutical Ingredients: MPT Development & Regulatory Considerations
Microarray patches: Breaking down the barriers to contraceptive care and HIV prevention for women across the globe
MPTs & the IMPT Platform
MPTs & the IMPT Platform May 2021 The MPTs & the IMPT Platform is a PowerPoint presentation created by the IMPT Secretariat at CAMI Health to help our colleagues integrate MPTs into their talks and presentations. Please email IMPT@cami-health.org with any feedback on how you used this information. Download the presentation slide deck CAMI Health […]
Toxicity study considerations for HIV prevention and MPT R&D
Advocates’ Guide to Multipurpose Prevention Technologies
The Power of MPTs: Combining Prevention of HIV, other STIs, and Pregnancy
The Power of MPTs: Combining Prevention of HIV, other STIs, and Pregnancy The IMPT’s Susanna Moore, Bethany Young Holt, and IMPT Advisory Council Member Thesla Palanee-Philips of Wits Reproductive Health and HIV Institute (Wits RHI), University of the Witwatersrand, presented an introductory MPT panel at USAID’s Global Health Science and Practice Technical Exchange (GHTechX) in […]
Integrating Socio-behavioral & Market Research into MPT R&D: Applying Lessons Learned
TRIO Study Brief: Long-Acting Injections for Women’s HIV Prevention in Sub-Saharan Africa: What End-Users Think
Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial
Microbicide Trials Network (MTN) Socio-behavioral Research Compendium
Multipurpose Prevention Technologies: Strategy recommendations to guide the most promising products from the lab to hands of women
Multipurpose Prevention Technologies: Strategy recommendations to guide the most promising products from the lab to hands of women January, 2021 Recent results from long-acting HIV prevention trials in parallel with the MPTs in the pipeline herald an exciting time for the MPT field. However, given finite resources and technical challenges to advance products from preclinical […]
The role of cervicovaginal microbiota on contraceptive and MPT development
HIV prevention is not all about HIV – using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protection
Use of International Standard ISO 10993-1, “Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process”
Use of International Standard ISO 10993-1, “Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process” September 2020 click to view Guidance Document In this Technical Brief: Product Type(s): Medical Devices Topic(s): Product Development Regulatory Issues Region(s): United States
MCI’s Lemonade Stand Series: “Multipurpose Prevention Technologies (MPTs) & Male Contraception
Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake
23rd International AIDS Conference (AIDS 2020: Virtual)
A novel vaginal pH regulator: results from the phase 3 AMPOWER contraception clinical trial
Assessment Report Dapivirine Vaginal Ring 25 mg
Sexual and Reproductive Health Research and Development: Understanding the Spectrum
Sexual and Reproductive Health Research and Development: Understanding the Spectrum 2020 G-Finder click to view Report In this Report: Topic(s): Funding landscape of MPTs
Towards a roadmap to advance non-hormonal contraceptive multipurpose prevention technologies: Strategic insights from key stakeholders
Bridging the gap: Advancing multipurpose prevention technologies from the lab into the hands of women
TRIO MPT Research Brief: Listening to Young Women in Kenya and South Africa to Inform Multipurpose “2-in-1” Products for HIV and Pregnancy Prevention
TRIO General Research Brief: What End-Users Think About HIV Prevention Products and Multipurpose Prevention Technologies (MPT)
The promise of MPTs
Toward a Roadmap for Biomedical HIV Prevention Investment Standards: Strategic Insights from Key Industry Stakeholders
MPT Trainee Photo Credit: Charmaine Cozzi, Wits RHI